Stay updated with breaking news from Richards Levy. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Shares of Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Rating) were down 3.7% on Tuesday . The stock traded as low as $235.73 and last traded at $236.36. Approximately 130,338 shares were traded during trading, a decline of 68% from the average daily volume of 401,477 shares. The stock had previously closed at $245.33. Wall Street […]
Forum Financial Management LP acquired a new stake in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Rating) during the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 2,630 shares of the biopharmaceutical company’s stock, valued at approximately $763,000. A number of other hedge […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Rating)’s share price traded down 4% on Thursday . The stock traded as low as $228.42 and last traded at $228.73. 53,915 shares were traded during mid-day trading, a decline of 87% from the average session volume of 411,752 shares. The stock had previously closed at $238.29. Analyst Upgrades […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Rating)’s share price crossed above its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $173.00 and traded as high as $245.92. Madrigal Pharmaceuticals shares last traded at $240.80, with a volume of 178,540 shares. Analyst Ratings Changes […]
Read the latest stock market news on MarketBeat. Get real-time analyst ratings, dividend information, earnings results, financials, headlines, insider trades and options data for any stock.